Press releases
-
SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant
-Research grant empowers future leaders in clinical research to advance breakthroughs in the prevention, detection, diagnosis and treatment of NMIBC Two fellows to receive SUO NMIBC research grants through educational grant from Ferring Pharmaceuticals Schaumburg, Ill and Parsippany, NJ – December 02, 2025 – The Society of Urologic Oncology (SUO) and Ferring Pharmaceuticals today announced the SUO NMIBC (non-muscle invasive bladder […]
-
Ferring Applauds New Jersey and Michigan for Proclamations Recognizing November as C. Difficile Infection Awareness Month
-Parsippany, NJ – November 12, 2025 – Ferring Pharmaceuticals thanks New Jersey and Michigan for recognizing November as Clostridioides difficile (C. diff) Infection Awareness Month. The proclamations raise important awareness of the severe impact of C. diff infection, a serious and potentially deadly infection. This is the sixth consecutive year the office of New Jersey Governor Phil Murphy demonstrated commitment […]
